Central nervous system progression in advanced non–small cell lung cancer patients with EGFR mutations in response to first-line treatment with two EGFR-TKIs, gefitinib and erlotin...

Por Li, Meng-Xia, He, Hao, Ruan, Zhi-Hua, Zhu, Yu-Xi, Li, Rong-Qing, He, Xiao, Lan, Bao-Hua, Zhang, Zhi-Min, Liu, Guo-Dong, Xiao, Hua-Liang, Wu, Yan, Zhu, Bo, Wang, Ge, Yang, Zhen-Zhou
Publicado no BMC Cancer (2017)